20(R)-Notoginsenoside R2

CAS No. 948046-15-9

20(R)-Notoginsenoside R2( —— )

Catalog No. M31437 CAS No. 948046-15-9

20(R)-Notoginsenoside R2 is a natural product with Promote blood circulation and improve myocardial ischemia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 209 In Stock
10MG 309 In Stock
25MG 521 In Stock
50MG 733 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    20(R)-Notoginsenoside R2
  • Note
    Research use only, not for human use.
  • Brief Description
    20(R)-Notoginsenoside R2 is a natural product with Promote blood circulation and improve myocardial ischemia.
  • Description
    20(R)-Notoginsenoside R2 is a natural product with Promote blood circulation and improve myocardial ischemia.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    948046-15-9
  • Formula Weight
    771
  • Molecular Formula
    C41H70O13
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 1-Methyl-2-undecylqu...

    1-Methyl-2-undecyl-4(1H)-quinolone, and dihydroevocarpine should also be served as the chemical markers together with evodiamine for the quality control of Evodia rutaecarpa (Juss.) Benth.

  • Vomicine

    Vomicine is a natural product from Strychnos nux-vomica, the S. nux-vomica extracts show antihyperglycemic activity in experimental animals.

  • Linzagolix

    Linzagolix is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone antagonist (GnRH antagonist) which is under development by Kissei Pharmaceutical and ObsEva for the treatment of uterine fibroids, endometriosis, and adenomyosis.